SLC28A2
Sodium/nucleoside cotransporter 2
Also known as: CNT2, HCNT2, HsT17153, S28A2_HUMAN, SPNT1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43868
- Gene
- SLC28A2
- Ensembl
- ENSG00000137860
- Chromosome
- 15
- Canonical length
- 658 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
OverviewNCBI Gene
Enables neurotransmitter transmembrane transporter activity and nucleoside transmembrane transporter activity. Involved in neurotransmitter transport; nucleoside transport; and purine nucleobase transmembrane transport. Located in apicolateral plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
658 residues, UniProt reviewed canonical sequence.
>O43868|SLC28A2
1 MEKASGRQSI ALSTVETGTV NPGLELMEKE VEPEGSKRTD AQGHSLGDGL GPSTYQRRSR
61 WPFSKARSFC KTHASLFKKI LLGLLCLAYA AYLLAACILN FQRALALFVI TCLVIFVLVH
121 SFLKKLLGKK LTRCLKPFEN SRLRLWTKWV FAGVSLVGLI LWLALDTAQR PEQLIPFAGI
181 CMFILILFAC SKHHSAVSWR TVFSGLGLQF VFGILVIRTD LGYTVFQWLG EQVQIFLNYT
241 VAGSSFVFGD TLVKDVFAFQ ALPIIIFFGC VVSILYYLGL VQWVVQKVAW FLQITMGTTA
301 TETLAVAGNI FVGMTEAPLL IRPYLGDMTL SEIHAVMTGG FATISGTVLG AFIAFGVDAS
361 SLISASVMAA PCALASSKLA YPEVEESKFK SEEGVKLPRG KERNVLEAAS NGAVDAIGLA
421 TNVAANLIAF LAVLAFINAA LSWLGELVDI QGLTFQVICS YLLRPMVFMM GVEWTDCPMV
481 AEMVGIKFFI NEFVAYQQLS QYKNKRLSGM EEWIEGEKQW ISVRAEIITT FSLCGFANLS
541 SIGITLGGLT SIVPHRKSDL SKVVVRALFT GACVSLISAC MAGILYVPRG AEADCVSFPN
601 TSFTNRTYET YMCCRGLFQS TSLNGTNPPS FSGPWEDKEF SAMALTNCCG FYNNTVCALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC28A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 14
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 87 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 87 nTPM
- duodenum: 64 nTPM
- rectum: 32 nTPM
- stomach: 22 nTPM
- gallbladder: 9.1 nTPM
- colon: 8.9 nTPM
Single-cell type
- foveolar cells: 136 nCPM
- enterocytes: 63 nCPM
- cardiomyocytes: 57 nCPM
- colonocytes: 46 nCPM
- enteric transient amplifying cells: 39 nCPM
- mucous neck cells: 39 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 4.8 nTPM
- pons: 4.7 nTPM
- amygdala: 4.5 nTPM
- cerebral cortex: 4.5 nTPM
- medulla oblongata: 4.5 nTPM
- basal ganglia: 4.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.53
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenosine transport
- azole transmembrane transport
- inosine transport
- neurotransmitter transport
- nucleobase-containing compound metabolic process
- nucleoside transmembrane transport
- purine nucleobase transmembrane transport
- purine nucleoside transmembrane transport
- pyrimidine-containing compound transmembrane transport
- retina homeostasis
- transport across blood-brain barrier
- uridine transmembrane transport
- xenobiotic metabolic process
- xenobiotic transmembrane transport
Molecular functions
- azole transmembrane transporter activity
- neurotransmitter transmembrane transporter activity
- nucleoside:sodium symporter activity
- purine nucleobase transmembrane transporter activity
- purine nucleoside transmembrane transporter activity
- pyrimidine- and adenosine-specific:sodium symporter activity
- uridine transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Concentrative nucleoside transporter N-terminal domain
- Concentrative nucleoside transporter
- Nucleoside transporter/FeoB GTPase, Gate domain
- Concentrative nucleoside transporter C-terminal domain
- Concentrative nucleoside transporter, metazoan/bacterial
- Na+ dependent nucleoside transporter N-terminus
- Na+ dependent nucleoside transporter C-terminus
- Nucleoside recognition
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC28A2 as an antibody target. Whether an autoantibody or antibody against SLC28A2 could matter depends on whether native SLC28A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC28A2 is annotated at the cell surface, where native SLC28A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC28A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...